AVEO Oncology Company Contacts

AVEO Oncology

http://www.aveooncology.com
AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell... Read More
Contacts

Country

United States

City

Boston

Headquarters

Boston, Massachusetts

Profile

Founded

2001

Industry

Biotechnology Research

Size

51 - 200

Specialties

Oncology

Funding

Total Rounds

16

Last Round

Mon Mar 22 2021

Last Round Series

Post IPO equity

Last Round Raised

$ 55,200,000